GlaxoSmithKline plc's (GSK) Hold Rating Reiterated at Shore Capital
Several other brokerages have also recently weighed in on GSK. Citigroup Inc. reiterated a buy rating on shares of GlaxoSmithKline plc in a research report on Monday, November 7th.
from Biotech News
0 Comments